The Impact of Diabetes on Brain Function in Childhood and Adolescence

Pediatric Clinics of North America

Volumn 62, Issue 4, 2015, Pages 911-927

  Cameron, Fergus J ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adolescents; Brain; Children; Cognition; Type 1 diabetes

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3;

ADOLESCENCE; ADULTHOOD; BRAIN EDEMA; BRAIN FUNCTION; BRAIN INJURY; CHILDHOOD; COGNITION; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIFFUSION COEFFICIENT; DISEASE DURATION; EDUCATION; ENERGY CONSUMPTION; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTELLIGENCE QUOTIENT; MENTAL HEALTH; METABOLIC REGULATION; MORBIDITY; NEUROPROTECTION; NEUROTOXICITY; REVIEW; ADOLESCENT; BRAIN DISEASES; CHILD; COGNITION DISORDERS; COMPLICATION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 1; HUMANS; RISK FACTORS;

EID: 84937728275     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2015.04.003     Document Type: Review

References (99)

1. Magistretti P.J., Pellerin L., Martin J.L. Brain energy metabolism an integrated cellular perspective. Psychopharmacology: the fourth generation of progress 2000, Raven Press, Ltd, New York, Available at:. http://www.acnp.org/g4/GN401000064/Default.htm, F.E. Bloom, D.J. Kupfer (Eds.).
2. Kuzawa C.W., Chugani H.T., Grossman L.I., et al. Metabolic costs and evolutionary implications of human brain development. Proc Natl Acad Sci USA 2014, 111:13010-13015.
3. Tomlinson D.R., Gardiner N.J. Glucose neurotoxicity. Nat Rev Neurosci 2008, 9:36-45.
4. Stanescu D.E., Lord K., Lipman T.H. The epidemiology of type 1 diabetes in children. Endocrinol Metab Clin North Am 2012, 41:679-694.
5. Chong J.W., Craig M.E., Cameron F.J., et al. Marked increase in type 1 diabetes mellitus in children aged 0-14 yr in Victoria, Australia, from 1999 to 2002. Pediatr Diabetes 2007, 8:67-73.
6. Anderson V., Spencer-Smith M., Wood A. Do children really recover better? Neurobehavioural plasticity after early brain insult. Brain 2011, 134:2197-2221.
7. Patino-Fernandez A.M., Delamater A.M., Applegate E.B., et al. Neurocognitive functioning on preschool-age children with type 1 diabetes. Pediatr Diabetes 2010, 11:424-430.
8. Aye T., Reiss A., Kesler S., et al. The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care 2011, 34:1458-1462.
9. Aye T., Barnea-Goraly N., Ambler C., et al. White matter structural differences in young children with type 1 diabetes: a diffusion tensor imaging study. Diabetes Care 2012, 35:2167-2173.
10. Shehata G., Eltayeb A. Cognitive function and event-related potentials in children with type 1 diabetes mellitus. JChild Neurol 2010, 25:469-474.
11. Hershey T., Perantie D.C., Warren S.L., et al. Frequency and timing of severe hypoglycaemia affects spatial memory in children with type 1 diabetes. Diabetes Care 2005, 28:2372-2377.
12. Cato M.A., Mauras N., Ambrosino J., et al. Cognitive functioning in young children with type 1 diabetes. JInt Neuropsychol Soc 2014, 20:238-247.
13. Marzelli M.J., Mazaika P.K., Barnea-Goraly N., et al. Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes 2014, 63(1):343-353.
14. Barnea-Goraly N., Raman M., Mazaika P., et al. Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care 2014, 37:332-340.
15. Perantie D.C., Wu J., Koller J.M., et al. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 2007, 30:2331-2337.
16. Perantie D.C., Koller J.M., Weaver P.M., et al. Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes 2011, 60:3006-3014.
17. Northam E.A., Rankins D., Lin A., et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009, 32:445-450.
18. Pell G.S., Lin A., Wellard R.M., et al. Age-related loss of brain volume and T2 relaxation time in youth with type 1 diabetes. Diabetes Care 2012, 35:513-519.
19. Lin A., Northam E.A., Rankins D., et al. Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset. Pediatr Diabetes 2010, 11:235-243.
20. Northam E.A., Lin A., Finch S., et al. Psychosocial well-being and functional outcomes in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2010, 33:1430-1437.
21. Wootton-Gorges S.L., Buonocore M.H., Caltagirone R.A., et al. Progressive decrease in N-acetylaspartate/Creatine ratio in a teenager with type 1 diabetes and repeated episodes of ketoacidosis without clinically apparent cerebral edema: evidence for permanent brain injury. AJNR Am J Neuroradiol 2010, 31:780-781.
22. Gaudieri P.A., Greer T.F., Chen R., et al. Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care 2008, 31:1892-1897.
23. Naguib J.M., Kulinskaya E., Lomax C.L., et al. Neuro-cognitive performance in children with type 1 diabetes - a meta-analysis. JPediatr Psychol 2009, 34:271-282.
24. Brands A.M., Biessels G.J., de Haan E.H., et al. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005, 28:726-735.
25. McCrimmon R.J., Ryan C.M., Frier B.M. Diabetes and cognitive dysfunction. Lancet 2012, 379:2291-2299.
26. Biessels G.J., Staekenborg S., Brunner E., et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
27. Dahlquist G., Källén B. School performance in children with type 1 diabetes-a population-based register study. Diabetologia 2007, 50:957-964. Available at:. http://www.ncbi.nlm.nih.gov/pubmed?term=Swedish%20Childhood%20Diabetes%20Study%20Group%5BCorporate%20Author%5D.
28. Persson S., Dahlquist G., Gerdtham U.G., et al. Impact of childhood-onset type 1 diabetes on schooling: a population-based register study. Diabetologia 2013, 56:1254-1262.
29. Hannonen R., Komulainen J., Rikonen R., et al. Academic skills in children with early-onset type 1 diabetes: the effects of diabetes-related risk factors. Dev Med Child Neurol 2012, 54:457-463.
30. McNally K., Rohan J., Pendley J.S., et al. Executive functioning, treatment adherence, and glycaemic control in children with type 1 diabetes. Diabetes Care 2010, 33:1159-1162.
31. Cameron F.J., Northam E.A., Ambler G.R., et al. Routine psychological screening in youth with type 1 diabetes and their parents: a notion whose time has come?. Diabetes Care 2007, 30:2716-2724.
32. Ducat L., Philipson L.H., Anderson B.J. The mental health comorbidities of diabetes. JAMA 2014, 312:691-692.
33. Reynolds K.A., Helgeson V. Children with diabetes compared to peers: depressed? Distressed?. Ann Behav Med 2011, 42:29-41.
34. Lustman P.J., Anderson R.J., Freedland K.E., et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23:934-942.
35. Anderson R.J., Freedland K.E., Clouse R.E., et al. The prevalence of comorbid depression in adults with diabetes. Diabetes Care 2001, 24:1069-1078.
36. McIntyre R.S., Kenna H.A., Nguyen H.T., et al. Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders?. Adv Ther 2010, 27:63-80.
37. Lyoo I.K., Yoon S.J., Musen G., et al. Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch Gen Psychiatry 2009, 66:878-887.
38. Knight S., Northam E., Donath S., et al. Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study. Diabetologia 2009, 52:193-198.
39. Knight S.J., Northam E.A., Cameron F.J., et al. Behaviour and metabolic control in children with type 1 diabetes mellitus on insulin pump therapy: 2-year follow-up. Diabet Med 2011, 28:1109-1112.
40. Jacobson A.M., Musen G., Ryan C.M., et al. Long-term effect of diabetes and its treatment on cognitive function. NEngl J Med 2007, 356:1842-1852.
41. Musen G., Jacobson A.M., Ryan C.M., et al. Impact of diabetes and its treatment on cognitive function among adolescents who participated in the diabetes control and complications trial. Diabetes Care 2008, 31:1933-1938.
42. Asvold B., Sand T., Hestad K., et al. Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycaemia. Diabetes Care 2010, 33:1945-1947.
43. Musen G., Lyoo I.K., Sparks C.R., et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006, 55:326-333.
44. Weinger K., Jacobson A.M., Musen G., et al. The effects of type 1 diabetes on cerebral white matter. Diabetologia 2008, 51:417-425.
45. Ferguson S.C., Blane A., Perros P., et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycaemia. Diabetes 2003, 52:149-156.
46. Ouwens D.M., van Duinkerken E., Schoonenboom S.N., et al. Cerebrospinal fluid levels of Alzheimer's disease biomarkers in middle-aged patients with type 1 diabetes. Diabetologia 2014, 57:2208-2214.
47. Qutub A.A., Hunt C.A. Glucose transport to the brain: a systems model. Brain Res Brain Res Rev 2005, 49:595-617.
48. Simpson I.A., Carruthers A., Vannucci S.J. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. JCereb Blood Flow Metab 2007, 27:1766-1791.
49. Abi-Saab W.M., Maggs D.G., Jones T., et al. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. JCereb Blood Flow Metab 2002, 22:271-279.
50. Oz G., Seaquist E.R., Kumar A., et al. Human brain glycogen content and metabolism: implications on its role in brain energy metabolism. Am J Physiol Endocrinol Metab 2007, 292:E946-E951.
51. Sima A.A. Encephalopathies: the emerging diabetic complications. Acta Diabetol 2010, 47:279-293.
52. Russo V., Higgins S., Werther G.A., et al. Effects of fluctuating glucose levels on neuronal cells invitro. Neurochem Res 2012, 37:1768-1782.
53. Owen O.E., Morgan A.P., Kemp H.G., et al. Brain metabolism during fasting. JClin Invest 1967, 46:1589-1595.
54. Isales C.M., Min L., Hoffman W.H. Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. JDiabetes Complications 1999, 13:91-97.
55. Guzmán M., Blázquez C. Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot Essent Fatty Acids 2004, 70:287-292.
56. Glaser N., Ngo C., Anderson S., et al. Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism. Diabetes 2012, 61:1831-1837.
57. Mitchell R.W., On N.H., Del Bigio M.R., et al. Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells. JNeurochem 2011, 17:735-746.
58. Gerich J.E. Control of glycaemia. Baillieres Clin Endocrinol Metab 1993, 7:551-586.
59. Meldrum B.S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. JNutr 2000, 130:1007S-1015S.
60. Hawkins R.A. The blood-brain barrier and glutamate. Am J Clin Nutr 2009, 90:867S-874S.
61. Page K.A., Williamson A., Yu N., et al. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support invitro synaptic transmission during acute hypoglycemia. Diabetes 2009, 58:1237-1244.
62. Rossetti P., Porcellati F., Busciantella Ricci N., et al. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. Diabetes 2008, 57:1905-1917.
63. Maran A., Cranston I., Lomas J., et al. Protection by lactate of cerebral function during hypoglycaemia. Lancet 1994, 343:16-20.
64. Suh S.W., Aoyama K., Matsumori Y., et al. Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 2005, 54:1452-1458.
65. Hallschmid M., Schultes B. Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?. Diabetologia 2009, 52:2264-2269.
66. Ott V., Benedict C., Schultes B., et al. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism. Diabetes Obes Metab 2012, 14:214-221.
67. McGaugh J.L., Gold P.E., Van Buskirk R., et al. Modulating influences of hormones and catecholamines on memory storage processes. Prog Brain Res 1975, 42:151-162.
68. Gomez-Sanchez E.P. The mammalian mineralocorticoid receptor: tying down a promiscuous receptor. Exp Physiol 2010, 95:13-18.
69. Ryan C.M., Atchison J., Puczynski S., et al. Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. JPediatr 1990, 117:32-38.
70. Gonder-Frederick L.A., Zrebiec J.F., Bauchowitz A.U., et al. Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study. Diabetes Care 2009, 32:1001-1006.
71. Daneman D. Type 1 diabetes. Lancet 2006, 367:847-858.
72. Cooper M.N., O'Connell S.M., Davis E.A., et al. Apopulation-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes. Diabetologia 2013, 56:2164-2170.
73. Maahs D.M., Hermann J.M., DuBose S.N., et al. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia 2014, 57:1578-1585.
74. Buckingham B., Wilson D.M., Lecher T., et al. Duration of nocturnal hypoglycaemia before seizure. Diabetes Care 2008, 31:2110-2112.
75. Jung S.L., Kim B.S., Lee K.S., et al. Magnetic resonance imaging and diffusion-weighted imaging changes after hypoglycemic coma. JNeuroimaging 2005, 15:193-196.
76. Rankins D., Wellard R.M., Cameron F., et al. The impact of acute hypoglycemia on neuropsychological and neurometabolite profiles in children with type 1 diabetes. Diabetes Care 2005, 28:2771-2773.
77. Lo L., Tan A.C., Umapathi T., et al. Diffusion-weighted MR imaging in early diagnosis and prognosis of hypoglycemia. AJNR Am J Neuroradiol 2006, 27:1222-1224.
78. Maekawa S., Aibiki M., Kikuchi K., et al. Time related changes in reversible MRI findings after prolonged hypoglycemia. Clin Neurol Neurosurg 2006, 108:511-513.
79. Davis E.A., Soong S.A., Byrne G.C., et al. Acute hyperglycaemia impairs cognitive function in children with IDDM. JPediatr Endocrinol Metab 1996, 9:455-461.
80. McDonnell C.M., Northam E.A., Donath S.M., et al. Hyperglycaemia and externalizing behavior in children with type 1 diabetes. Diabetes Care 2007, 30:2211-2215.
81. Wolfsdorf J., Craig M.E., Daneman D. Diabetic ketoacidosis. Pediatr Diabetes 2007, 8:28-43.
82. Glaser N.S., Wootton-Gorges S.L., Marcin J.P., et al. Mechanism of cerebral edema in children with diabetic ketoacidosis. JPediatr 2004, 145:164-171.
83. Figueroa R.E., Hoffman W.H., Momin Z., et al. Study of subclinical cerebral edema in diabetic ketoacidosis by magnetic resonance imaging T2 relaxometry and apparent diffusion coefficient maps. Endocr Res 2005, 31:345-355.
84. Yuen N., Anderson S.E., Glaser N., et al. Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes 2008, 57:2588-2594.
85. Glaser N., Yuen N., Anderson S.E., et al. Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide. Diabetes 2010, 59:702-709.
86. Glaser N.S., Wootton-Gorges S.L., Buonocore M.H., et al. Subclinical cerebral edema in children with diabetic ketoacidosis randomized to 2 different rehydration protocols. Pediatrics 2013, 131:e73-e80.
87. Wootton-Gorges S.L., Buonocore M.H., Kuppermann N., et al. Detection of cerebral {beta}-hydroxy butyrate, acetoacetate, and lactate on proton MR spectroscopy in children with diabetic ketoacidosis. AJNR Am J Neuroradiol 2005, 26:1286-1291.
88. Wootton-Gorges S.L., Buonocore M.H., Kuppermann N., et al. Cerebral proton magnetic resonance spectroscopy in children with diabetic ketoacidosis. AJNR Am J Neuroradiol 2007, 28:895-899.
89. Cameron F.J., Scratch S., Nadebaum C., et al. Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in childhood. Diabetes Care 2014, 37:1554-1562.
90. Cameron F.J., Baghurst P.A., Rodbard D. Assessing glycaemic variation: why, when and how?. Pediatr Endocrinol Rev 2010, 7(Suppl 3):432-444.
91. Neylon O.M., Baghurst P.A., Cameron F.J. The minimum duration of sensor data from which glycaemic variability can be consistently assessed. JDiabetes Sci Technol 2014, 8:273-276.
92. Piconi L., Quagliaro L., Assaloni R., et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 2006, 22:198-203.
93. Ferguson S.C., Blane A., Wardlaw J., et al. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 2005, 28:1431-1437.
94. Kaufmann L., Pixner S., Starke M., et al. Neurocognition and brain structure in pediatric patients with type 1 diabetes. JPediatr Neuroradiol 2012, 1:25-35.
95. Ly T., Anderson M., McNamara K., et al. Neurocognitive outcomes in young adults with early-onset type 1 diabetes. Diabetes Care 2011, 34:2192-2197.
96. Rovet J.F., Ehrlich R.M. The effect of hypoglycaemic seizures on cognitive function in children with diabetes: a 7-year prospective study. JPediatr 1999, 134:503-506.
97. Perantie D.C., Lim A., Wu J., et al. Effects of prior hypoglycaemia and hyperglycaemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes 2008, 9:87-95.
98. Ryan C.M. Why is cognitive function associated with the development of diabetes in early life? The diathesis hypothesis. Pediatr Diabetes 2006, 7:289-297.
99. Northam E.A., Cameron F.J. Understanding the diabetic brain: new technologies but old challenges. Diabetes 2013, 62:341-342.